Ontario Brain Institute Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT01769092
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Ontario Brain Institute | The Epilepsy Research Program of the Ontario Brain Institute